Patent №
US 7,844,560
Granted
2010-11-30
Filed 2007
Owner
SIEMENS MEDICAL SOLUTIONS USA, INC.
Lab
—
AI components
1
planning
Assignment
Recorded
Dataset
AIPD
2023_r1 edition
Application
11735720
Automated treatment planning is provided with individual specific consideration. One or more prognosis models indicate survivability as a function of patient specific information for a given dose. By determining survivability for a plurality of doses, the biological model represented by survivability as a function of dose is determined from the specific patient. Similarly, the chances of complications or side effects are determined. The chance of survivability and chance of complication are used as or instead of the tumor control probability and normal tissue complications probability, respectively. The desired tumor dosage and tolerance dosage are selected as a function of the patient specific dose distributions. The selected dosages are input to an inverse treatment planning system for establishing radiation treatment parameters.
AI classification
Ownership
SIEMENS MEDICAL SOLUTIONS USA, INC.
assignment · 196910164
Assignors
KRISHNAN, SRIRAM, RAO, R. BHARAT, AMIES, CHRISTOPHER JUDE
On an employer assignment, the assignors are typically the inventors.